As of 2025-10-30, the Relative Valuation of Heron Therapeutics Inc (HRTX) is (0.09) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.17 USD, the upside of Heron Therapeutics Inc based on Relative Valuation is -108.1%.
The range of the Relative Valuation is (0.08) - (0.10) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.5x - 23.7x | 19.6x |
| Forward P/E multiples | 15.4x - 20.1x | 17.8x |
| Fair Price | (0.08) - (0.10) | (0.09) |
| Upside | -106.7% - -108.7% | -108.1% |
| Date | P/E |
| 2025-10-29 | -230.37 |
| 2025-10-28 | -234.31 |
| 2025-10-27 | -232.34 |
| 2025-10-24 | -236.27 |
| 2025-10-23 | -234.31 |
| 2025-10-22 | -234.31 |
| 2025-10-21 | -255.96 |
| 2025-10-20 | -265.81 |
| 2025-10-17 | -254.00 |
| 2025-10-16 | -255.96 |
| 2025-10-15 | -265.81 |
| 2025-10-14 | -259.90 |
| 2025-10-13 | -255.96 |
| 2025-10-10 | -252.03 |
| 2025-10-09 | -257.93 |
| 2025-10-08 | -265.81 |
| 2025-10-07 | -259.90 |
| 2025-10-06 | -263.84 |
| 2025-10-03 | -259.90 |
| 2025-10-02 | -255.96 |
| 2025-10-01 | -246.12 |
| 2025-09-30 | -248.09 |
| 2025-09-29 | -250.06 |
| 2025-09-26 | -238.24 |
| 2025-09-25 | -240.21 |
| 2025-09-24 | -246.12 |
| 2025-09-23 | -244.15 |
| 2025-09-22 | -255.96 |
| 2025-09-19 | -242.18 |
| 2025-09-18 | -254.00 |
| 2025-09-17 | -238.24 |
| 2025-09-16 | -244.15 |
| 2025-09-15 | -244.15 |
| 2025-09-12 | -248.09 |
| 2025-09-11 | -252.03 |
| 2025-09-10 | -250.06 |
| 2025-09-09 | -255.96 |
| 2025-09-08 | -255.96 |
| 2025-09-05 | -257.93 |
| 2025-09-04 | -259.90 |
| 2025-09-03 | -261.87 |
| 2025-09-02 | -259.90 |
| 2025-08-29 | -265.81 |
| 2025-08-28 | -273.69 |
| 2025-08-27 | -267.78 |
| 2025-08-26 | -277.62 |
| 2025-08-25 | -271.72 |
| 2025-08-22 | -275.65 |
| 2025-08-21 | -259.90 |
| 2025-08-20 | -255.96 |